Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut U Klein

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
International Journal of Cardiology|August 17, 2013
Impact of atrial fibrillation on early complications and one year-survival after cardioverter defibrillator implantation: results from the German DEVICE registryJulia Köbe, Kristina Wasmer, Dietrich Andresen, et al.
Pacing and Clinical Electrophysiology : PACE|November 6, 2009
Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD)Helmut U Klein, Ulf Meltendorf, Sven Reek, et al.
Journal of the American College of Cardiology|November 16, 2005
Cardiac resynchronization therapy improves heart rate profile and heart rate variability of patients with moderate to severe heart failureCecilia Fantoni, Santi Raffa, Francois Regoli, et al.
Heart Rhythm|November 4, 2010
Long-term implications of cumulative right ventricular pacing among patients with an implantable cardioverter-defibrillatorAlon Barsheshet, Arthur J Moss, Scott McNitt, et al.
European Heart Journal|November 16, 2010
Time-dependent benefit of preventive cardiac resynchronization therapy after myocardial infarctionAlon Barsheshet, Arthur J Moss, Michael Eldar, et al.
Circulation|January 30, 2008
Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expressionAndreas Goette, Alicja Bukowska, Uwe Lendeckel, et al.
European Heart Journal|December 4, 2003
Treatment of atrial fibrillation with an implantable atrial defibrillator--long term resultsJ Christoph Geller, Sven Reek, Carl Timmermans, et al.
European Journal of Heart Failure|February 26, 2008
Long-term outcome in diabetic heart failure patients treated with cardiac resynchronization therapyCecilia Fantoni, François Regoli, Ali Ghanem, et al.
Journal of the American College of Cardiology|June 11, 2011
Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy)Alon Barsheshet, Paul J Wang, Arthur J Moss, et al.
Thrombosis Research|January 31, 2006
Quality of anticoagulation with unfractionated heparin plus phenprocoumon for the prevention of thromboembolic complications in cardioversion for non-valvular atrial fibrillation. Sub-analysis from the Anticoagulation in Cardioversion using Enoxaparin (ACE) trialCaroline Schmidt-Lucke, W Dieter Paar, Christoph Stellbrink, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
International Journal of Cardiology|August 17, 2013
Impact of atrial fibrillation on early complications and one year-survival after cardioverter defibrillator implantation: results from the German DEVICE registryJulia Köbe, Kristina Wasmer, Dietrich Andresen, et al.
Pacing and Clinical Electrophysiology : PACE|November 6, 2009
Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD)Helmut U Klein, Ulf Meltendorf, Sven Reek, et al.
Journal of the American College of Cardiology|November 16, 2005
Cardiac resynchronization therapy improves heart rate profile and heart rate variability of patients with moderate to severe heart failureCecilia Fantoni, Santi Raffa, Francois Regoli, et al.
Heart Rhythm|November 4, 2010
Long-term implications of cumulative right ventricular pacing among patients with an implantable cardioverter-defibrillatorAlon Barsheshet, Arthur J Moss, Scott McNitt, et al.
European Heart Journal|November 16, 2010
Time-dependent benefit of preventive cardiac resynchronization therapy after myocardial infarctionAlon Barsheshet, Arthur J Moss, Michael Eldar, et al.
Circulation|January 30, 2008
Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expressionAndreas Goette, Alicja Bukowska, Uwe Lendeckel, et al.
European Heart Journal|December 4, 2003
Treatment of atrial fibrillation with an implantable atrial defibrillator--long term resultsJ Christoph Geller, Sven Reek, Carl Timmermans, et al.
European Journal of Heart Failure|February 26, 2008
Long-term outcome in diabetic heart failure patients treated with cardiac resynchronization therapyCecilia Fantoni, François Regoli, Ali Ghanem, et al.
Journal of the American College of Cardiology|June 11, 2011
Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy)Alon Barsheshet, Paul J Wang, Arthur J Moss, et al.
Thrombosis Research|January 31, 2006
Quality of anticoagulation with unfractionated heparin plus phenprocoumon for the prevention of thromboembolic complications in cardioversion for non-valvular atrial fibrillation. Sub-analysis from the Anticoagulation in Cardioversion using Enoxaparin (ACE) trialCaroline Schmidt-Lucke, W Dieter Paar, Christoph Stellbrink, et al.
Pageof 12